Related Experiment Video

Updated: Jun 27, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

Epidemiology of invasive fungal infection

J J Castón-Osorio1, A Rivero, J Torre-Cisneros

  • 1Unidad de Gestión Clínica de Enfermedades Infecciosas, Hospital Universitario Reina Sofía, Córdoba, Spain. juanjoco2005@yahoo.es

International Journal of Antimicrobial Agents
|December 17, 2008
PubMed

Insights

Invasive fungal infections are increasing in immunocompromised patients, with shifts towards molds like Aspergillus and Mucorales due to antifungal prophylaxis. Understanding these changes is crucial for better treatment and prevention strategies.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Immunocompromised Host Research

Background:

  • Invasive fungal infections (IFIs) pose a significant threat to immunocompromised patients, contributing to morbidity and mortality.
  • The widespread use of azole antifungals for Candida prophylaxis correlates with rising rates of invasive aspergillosis and Mucorales infections.
  • Emerging data indicate novel risk factors and varied timelines for the onset of IFIs.

Purpose of the Study:

  • To highlight the evolving epidemiology of invasive fungal infections in immunosuppressed populations.
  • To underscore the importance of updated knowledge on risk factors and infection timelines.
  • To inform the development of improved therapeutic and prophylactic strategies for IFIs.

Main Methods:

  • Review of current epidemiological data on IFIs.
  • Analysis of trends in fungal infections associated with antifungal prophylaxis.
  • Identification of new risk factors and onset patterns for IFIs.

Main Results:

  • A documented increase in invasive aspergillosis and Mucorales infections.
  • Association between azole prophylaxis and shifts in fungal pathogen incidence.
  • Discovery of previously unrecognized risk factors and altered infection onset dynamics.

Conclusions:

  • Updated understanding of IFI epidemiology and risk factors is essential for immunosuppressed patients.
  • Therapeutic strategies and prophylaxis require adaptation to the changing landscape of fungal infections.
  • Improved patient outcomes depend on timely and targeted interventions based on current epidemiological insights.

More Related Videos

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance08:45

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...